• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

MRI/TRUS 融合靶向活检与系统经直肠活检的癌症检出率和检查者间变异性。

Cancer detection rates and inter-examiner variability of MRI/TRUS fusion targeted biopsy and systematic transrectal biopsy.

机构信息

Department of Urology, Thomayer Hospital and 3rd Faculty of Medicine, Charles University, Prague, Czech Republic.

Department of Urology, 1.

出版信息

Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2020 Sep;164(3):314-319. doi: 10.5507/bp.2019.050. Epub 2019 Oct 10.

DOI:10.5507/bp.2019.050
PMID:31602045
Abstract

BACKGROUND

Software-based MRI/TRUS fusion biopsy depends on the coordination of several steps, and inter-examiner differences could influence the results. The aim of this bicentric prospective study was to compare the detection rates of MRI/TRUS fusion targeted biopsy (TG) and systematic biopsy (SB), and the detection rates of examiners with different levels of previous experience in prostate biopsy.

METHODS

A total of 419 patients underwent MRI based on a suspicion of prostate cancer with elevated PSA levels. MRI was positive in 395 patients (221 in the first biopsy group [FB] and 174 in the repeated biopsy group [RB]). A subsequent TG, followed by a SB, was performed on these patients by four different examiners.

RESULTS

In the detection of clinically significant prostate cancer, a significant difference was found for TG+SB against SB in the RB group (35.1% vs. 25.3%, P=0.047). In the detection of clinically insignificant prostate cancer, the SB had a significantly higher detection rate than TG in both subgroups (FB: 11.9% vs. 4.7%, P=0.008; RB: 13.8% vs. 6.9%, P=0.034). A significant difference was found between the four examiners in the FB for TG (P=0.028), SB (P=0.036), and TG+SB (P=0.017).

CONCLUSION

MRI/TRUS TG in combination with SB had significantly higher detection rates than SB in the RB group only. Differences in detection rates between examiners were dependent on the level of previous experience with TRUS guided biopsy.

摘要

背景

基于软件的 MRI/TRUS 融合活检依赖于多个步骤的协调,而检查者之间的差异可能会影响结果。本项双中心前瞻性研究的目的是比较 MRI/TRUS 融合靶向活检(TG)和系统活检(SB)的检出率,以及在前列腺活检方面具有不同既往经验的检查者的检出率。

方法

共 419 例患者因 PSA 水平升高接受 MRI 检查,怀疑患有前列腺癌。395 例患者 MRI 阳性(首次活检组 [FB] 221 例,重复活检组 [RB] 174 例)。对这些患者进行了 TG,随后进行了 SB,由四位不同的检查者进行。

结果

在检测临床上显著的前列腺癌时,RB 组 TG+SB 与 SB 之间存在显著差异(35.1%比 25.3%,P=0.047)。在检测临床上不显著的前列腺癌时,SB 在两个亚组中的检出率均明显高于 TG(FB:11.9%比 4.7%,P=0.008;RB:13.8%比 6.9%,P=0.034)。在 FB 中,四位检查者在 TG(P=0.028)、SB(P=0.036)和 TG+SB(P=0.017)方面存在显著差异。

结论

MRI/TRUS TG 联合 SB 在 RB 组的检出率明显高于 SB。检查者之间的检出率差异取决于 TRUS 引导活检的既往经验水平。

相似文献

1
Cancer detection rates and inter-examiner variability of MRI/TRUS fusion targeted biopsy and systematic transrectal biopsy.MRI/TRUS 融合靶向活检与系统经直肠活检的癌症检出率和检查者间变异性。
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2020 Sep;164(3):314-319. doi: 10.5507/bp.2019.050. Epub 2019 Oct 10.
2
A Randomized Controlled Trial To Assess and Compare the Outcomes of Two-core Prostate Biopsy Guided by Fused Magnetic Resonance and Transrectal Ultrasound Images and Traditional 12-core Systematic Biopsy.一项随机对照试验,旨在评估和比较融合磁共振和经直肠超声图像引导的双芯前列腺活检与传统 12 芯系统活检的结果。
Eur Urol. 2016 Jan;69(1):149-56. doi: 10.1016/j.eururo.2015.03.041. Epub 2015 Apr 7.
3
Comparison of Cancer Detection Rates Between TRUS-Guided Biopsy and MRI-Targeted Biopsy According to PSA Level in Biopsy-Naive Patients: A Propensity Score Matching Analysis.在初次活检的患者中,根据 PSA 水平比较 TRUS 引导下活检与 MRI 靶向活检的癌症检出率:倾向评分匹配分析。
Clin Genitourin Cancer. 2019 Feb;17(1):e19-e25. doi: 10.1016/j.clgc.2018.09.007. Epub 2018 Sep 13.
4
Primary magnetic resonance imaging/ultrasonography fusion-guided biopsy of the prostate.原发性磁共振成像/超声融合引导前列腺活检。
BJU Int. 2018 Aug;122(2):211-218. doi: 10.1111/bju.14212. Epub 2018 Apr 17.
5
Cognitive MRI-TRUS fusion-targeted prostate biopsy according to PI-RADS classification in patients with prior negative systematic biopsy results.根据PI-RADS分类,对既往系统性活检结果为阴性的患者进行认知性MRI-TRUS融合靶向前列腺活检。
J Chin Med Assoc. 2016 Nov;79(11):618-624. doi: 10.1016/j.jcma.2016.05.004. Epub 2016 Aug 23.
6
Comparison of free-hand transperineal mpMRI/TRUS fusion-guided biopsy with transperineal 12-core systematic biopsy for the diagnosis of prostate cancer: a single-center prospective study in China.经会阴徒手磁共振成像/超声融合引导活检与经会阴12针系统活检诊断前列腺癌的比较:中国一项单中心前瞻性研究
Int Urol Nephrol. 2017 Mar;49(3):439-448. doi: 10.1007/s11255-016-1484-8. Epub 2016 Dec 22.
7
Additive Value of Transrectal Systematic Ventral Biopsies in Combination with Magnet Resonance Imaging/Ultrasound Fusion-Guided Biopsy in Patients with 3 or More Negative Prostate Biopsies.对于前列腺活检次数≥3 次且均为阴性的患者,经直肠系统前列腺腹侧面穿刺联合 MRI/超声融合引导活检的附加价值。
Urol Int. 2020;104(3-4):205-213. doi: 10.1159/000504266. Epub 2019 Dec 4.
8
Diagnostic performance of MRI/TRUS fusion-guided biopsies vs. systematic prostate biopsies in biopsy-naïve, previous negative biopsy patients and men undergoing active surveillance.MRI/TRUS 融合引导活检与系统前列腺活检在初次活检阴性和接受主动监测的患者中的诊断性能比较。
Minerva Urol Nephrol. 2021 Jun;73(3):357-366. doi: 10.23736/S2724-6051.20.03758-3. Epub 2021 Mar 26.
9
The FUTURE Trial: A Multicenter Randomised Controlled Trial on Target Biopsy Techniques Based on Magnetic Resonance Imaging in the Diagnosis of Prostate Cancer in Patients with Prior Negative Biopsies.FUTURE 试验:一项基于磁共振成像的靶向活检技术在既往阴性前列腺穿刺活检患者中诊断前列腺癌的多中心随机对照研究。
Eur Urol. 2019 Apr;75(4):582-590. doi: 10.1016/j.eururo.2018.11.040. Epub 2018 Dec 3.
10
Not All Multiparametric Magnetic Resonance Imaging-targeted Biopsies Are Equal: The Impact of the Type of Approach and Operator Expertise on the Detection of Clinically Significant Prostate Cancer.并非所有多参数磁共振成像靶向活检都一样:方法类型和操作者专业水平对检测临床显著前列腺癌的影响。
Eur Urol Oncol. 2018 Jun;1(2):120-128. doi: 10.1016/j.euo.2018.02.002. Epub 2018 May 15.

引用本文的文献

1
Evidence-based guideline recommendations on multiparametric magnetic resonance imaging in the diagnosis of clinically significant prostate cancer: A Cancer Care Ontario updated clinical practice guideline.基于证据的多参数磁共振成像在临床显著性前列腺癌诊断中的指南建议:安大略癌症护理更新的临床实践指南。
Can Urol Assoc J. 2022 Feb;16(2):16-23. doi: 10.5489/cuaj.7425.
2
A prospective study on inter-operator variability in semi-robotic software-based MRI/TRUS-fusion targeted prostate biopsies.基于半机器人软件的 MRI/TRUS 融合靶向前列腺活检中操作者间变异性的前瞻性研究。
World J Urol. 2022 Feb;40(2):427-433. doi: 10.1007/s00345-021-03891-3. Epub 2021 Nov 26.